United States

People: Danaher Corp (DHR.N)

DHR.N on New York Stock Exchange

1:23pm EDT
Change (% chg)

$-0.47 (-0.54%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Zerhouni, Elias 

Dr. Elias A. Zerhouni, M.D. is Independent Director of the Company. He has served as President, Global Research & Development, for Sanofi-Aventis, a global pharmaceutical company, since January 2011. From 1996 to 2002, Dr. Zerhouni served as Chair of the Russell H. Morgan Department of Radiology and Radiological Sciences, Vice Dean for Research and Executive Vice Dean of the Johns Hopkins School of Medicine. From 2002 to November 2008, Dr. Zerhouni served as director of the National Institutes of Health (“NIH”), and from November 2008 to December 2010 he provided advisory and consulting services to various non-profit and other organizations as Chairman and President of Zerhouni Holdings. Dr. Zerhouni, a physician, scientist and world-renowned leader in radiology research, is widely viewed as one of the leading authorities in the United States on emerging trends and issues in medicine and medical care. These insights, as well as his deep, technical knowledge of the research and clinical applications of medical technologies, are of considerable importance given Danaher’s strategic expansion in the medical technologies markets. Dr. Zerhouni’s government experience also gives him a strong understanding of how government agencies work, and his experience growing up in North Africa, together with the global nature of the issues he faced at NIH, give him a global perspective that is valuable to Danaher.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Awards, USD 186,970
Long-Term Incentive Plans, USD --
All Other, USD 67,068
Fiscal Year Total, USD 254,038

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Steven Rales


Daniel Comas


Rainer Blair


William Daniel


Robert Lutz


Brian Ellis

As Of  30 Dec 2016